๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-21

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (NCT06672549)

A Master Protocol for a Randomized, Controlled, Clinical Platform Trial to Investigate the Efficacy and Safety of Interventions for Chronic Weight Management in Pediatric Participants With Obesity or Overweight

๐ŸŸข Recruiting Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Eli Lilly and Company

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.

Who can join: Review the eligibility criteria below.

Location: University of Arizona โ€” Tucson, Arizona

Age range: 6 Years to 17 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (117 Sites)

Showing the first 25 of 117 sites.

  • University of Arizona โ€” Tucson, Arizona
  • Loma Linda University School of Medicine โ€” Loma Linda, California
  • Childrens Hospital of Los Angeles โ€” Los Angeles, California
  • UCLA Mattel Children's Hospital โ€” Los Angeles, California
  • Children's Hospital of Orange County - Orange โ€” Orange, California
  • Carey Chronis MD Pediatric, Infant and Adolescent Medicine โ€” Oxnard, California
  • Children's Hospital Colorado โ€” Colorado Springs, Colorado
  • Yale School of Medicine - Yale Diabetes Center (YDC)) Trials โ€” New Haven, Connecticut
  • Stamford Therapeutics Consortium โ€” Stamford, Connecticut
  • William A. Shands Hospital at the University of Florida โ€” Gainesville, Florida
  • Florida Hospital- Center for Pediatric Research โ€” Orlando, Florida
  • Nemours Children's Health โ€” Orlando, Florida
  • All Childrens Hospital โ€” St. Petersburg, Florida
  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics โ€” Atlanta, Georgia
  • Ann and Robert Lurie Children's Hospital of Chicago โ€” Chicago, Illinois
  • University of Illinois at Chicago โ€” Chicago, Illinois
  • Riley Hospital for Children โ€” Indianapolis, Indiana
  • Norton Children's Endocrinology โ€” Louisville, Kentucky
  • Velocity Clinical Research โ€” Lafayette, Louisiana
  • Johns Hopkins Children's Center โ€” Baltimore, Maryland
  • Boston Children's Hospital โ€” Boston, Massachusetts
  • Helen Devos Childrens' Hospital - PIN โ€” Grand Rapids, Michigan
  • University of Minnesota Masonic Children's Hospital โ€” Minneapolis, Minnesota
  • Mayo Clinic - PIN โ€” Rochester, Minnesota
  • Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center โ€” Saint Paul, Minnesota

๐Ÿ“ž Contact the Study Coordinator

Phone: (317) 615-4559

Email: LillyTrials@Lilly.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Obesity clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—